DAA treatment for hepatitis C among people who inject drugs episode artwork

EPISODE · Oct 25, 2018 · 11 MIN

DAA treatment for hepatitis C among people who inject drugs

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

NOW PLAYING

DAA treatment for hepatitis C among people who inject drugs

0:00 11:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 11 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on October 25, 2018.

What is this episode about?

Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!